The Team


MHG operates via a network-based consortium model, leveraging experienced and reliable research partners across a wide variety of disciplines, seamlessly integrated via a single point of contact to our clients. Our core consultant network encompasses statisticians, health economists, country-specific market access experts, and medical writers. We maintain an extensive global network of physician and payer respondents to provide up-to-date insights on the pharmaceutical, payer, and HTA landscape in countries worldwide.

Rachel Beckerman



Dr. Beckerman is the founder of MHG, and has over a decade of experience in biotechnology commercial assessment and biomedical research.Dr. Beckerman’s work is centred around clinical and economic value demonstration to HTA and payer bodies in the developed and emerging markets, with a focus on the development of comprehensive reimbursement, HTA and HEOR strategies and the construction of evidence-based and user-friendly health economic models.


  • London School of Economics – Statistical Methods in Health Economics Certificate
  • Columbia University – Ph.D., Biochemistry and Molecular Biophysics
  • McGill University – B.Sc., Biochemistry

Other Professional Experience

  • Principal, Value Demonstration, CBPartners
  • Senior Consultant, Global Market Access, Insight Strategy Advisors
Nate Smith



Dr. Smith is a principal at MHG, with strong experience across a variety of quantitative analytical methods, which he has applied to HEOR and biopharma commercial assessment. Dr. Smith’s work is centred around HEOR strategy and economic evidence generation, including CUA/CCAs, BIMs, and ITC/NMAs, developed for a diverse set of private and public payer bodies, in addition to commercial forecasting.


  • Yale University – Ph.D., Neuroscience
  • Duke University – B.Sc., Biomedical and Electrical Engineering

Other Professional Experience

  • Associate, Biotechnology Equity Research, BMO Capital Markets
  • Associate, Value Demonstration, CBPartners

Dennis Meletiche, Pharm.D


Dr. Meletiche currently serves as the Chief Strategy Advisor at MHG where is responsible for strategic guidance, client relations, and oversight and execution of select client engagements. Dennis brings to MHG nearly 20 years of global market access and HEOR experience in the pharmaceutical industry, including building and developing global, US and field teams for several leading biopharma companies. Over his long and successful career in the pharmaceutical industry, Dennis has developed broad and deep level of market access expertise including significant launch experience across multiple therapeutic areas including neurology, psychiatry, metabolic disorders, reproductive health, and infectious disease. Prior to joining MHG, Dr. Meletiche was the Vice President of Global HEOR team at Biogen. He has also held several senior level roles at EMD Serono and Johnson & Johnson.


  • Thomas Jefferson University/University of Pennsylvania – GSK Post doctoral fellowship in HEOR
  • SUNY Buffalo – Pharm.D.

Other Professional Experience

  • Vice President HEOR, Biogen
  • Vice President, Market Access & Health Outcomes – EMD Serono
  • Various HEOR roles of escalating responsibility – Johnson & Johnson


We work closely with you and tailor our approach based on your specific needs and those of your stakeholders.